Related Experiment Videos
HIV-1 inactivation by nucleic acid aptamers
Daniel M Held1, Jay D Kissel, James T Patterson
1Department of Biology, Indiana University, Bloomington, IN 47405, USA.
Frontiers in Bioscience : a Journal and Virtual Library
|September 9, 2005
Summary
Non-coding nucleic acids, like aptamers, show promise as novel HIV-1 inhibitors by targeting essential viral proteins. Further research into aptamer-target interactions is crucial for developing effective alternative therapies.
Area of Science:
- Biochemistry
- Molecular Biology
- Virology
Background:
- Current HIV-1 small-molecule therapeutics face challenges with drug resistance and adverse side effects.
- Non-coding nucleic acids, including aptamers, demonstrate significant potential for inhibiting HIV-1 replication.
- Aptamers function by interfering with critical viral proteins essential for the HIV-1 lifecycle.
Purpose of the Study:
- To provide an overview of biochemical and cell culture analyses of aptamers targeting HIV-1.
- To discuss the mechanisms by which aptamers inhibit various stages of the HIV-1 replication cycle.
- To highlight the importance of aptamer-target interactions in determining antiviral efficacy.
Main Methods:
- Review of biochemical analyses of aptamer-target interactions.
- Examination of cell culture studies evaluating aptamer efficacy against HIV-1.
- Focus on aptamers targeting viral enzymes, expression, packaging, and entry.
Main Results:
- A growing list of aptamers targeting diverse HIV-1 components has been identified.
- Aptamers effectively inhibit viral enzymes (reverse transcriptase, protease, integrase).
- Aptamers interfere with viral expression (Rev/RRE, Tat/TAR), packaging (Gag, MA, NC), and entry (gp120).
Conclusions:
- Nucleic acid-based aptamers represent a promising alternative therapeutic strategy for HIV-1 infection.
- Understanding the biochemical properties of aptamer-target interactions is key to optimizing antiviral activity.
- Further investigation into aptamers and other nucleic acid strategies (RNAi, antisense, ribozymes) is warranted for HIV-1 control.